Abstract:Objective To investigate the clinical efficacy of the treatment of long-term non-invasive positive pressure ventilation (NIPPV) combined with inhaling corticosteroids in patients with stable chronic o0bstructive pulmonary disease(COPD) complicated with respiratory failure,and to investigate the impact of longterm NIPPV combined with inhaling corticosteroids on serum levels of matrix metalloproteinase-9 (MMP-9).Methods Eighty outpatients of stable severe COPD complicated with respiratory failure divided them equally into two treatment groups (the experimental and the control groups).The two groups of patients were given oxygen therapy,inhalation of Salmeterol and fluticasone propionate powder for one year.The experimental group received additionally NIPPV therapy for 1 year.The outcomes measured included St.George's questionnaire (SGRQ) score,MMRC score,6-min working time (6-MWT),arterial partial pressure of oxygen (PaO2),partial pressure of carbon dioxide(PaCO2),Forced expiratory volume in 1 (FEV1％),and the serum levels of MMP-9 before and after treatment,and frequency of acute exacerbations of COPD and hospital says in the last one year and the following 12 months.Results After 1 year,the differences of SGRQ score,MMRC score,6-MWT,PaO2,PaCO2,FEV1％,MMP-9 in the experimental group ((63.38 ±4.46) vs.(52.93 ±4.30),t =10.67,P =0.00;(3.60±0.50) vs.(2.40 ±0.50),t =10.82,P=0.00;(159.90 ±6.50) m vs.(247.10±9.66) m,t=47.39,P=0.00;(56.85 ± 1.67) mm Hg vs.(66.10 ±2.59) mm Hg,t =10.67,P =0.00;(60.38 ±3.58)mm Hgvs.(51.88 ±3.05)mm Hg,t=10.82,P=0.00; (38.93 ±3.22)％ vs.(42.12 ±3.11)％,t=47.39,P =0.00;(182.58 ±6.60) μg/L vs.(171.73 ±6.19) μg/L,t =7.58,P =0.00) were statistically significant compared to the control group ((63.88 ± 4.88) vs.(54.30 ± 4.13),t =8.77,P =0.00; (3.65 ± 0.48) vs.(2.70±0.46),t =8.97,P =0.00;(157.98 ±5.97) m vs.(218.08±13.12) m,t =26.38,P=0.00;(56.65 ±1.51)mm Hg vs.(62.60 ± 1.91)mm Hg,t=8.77,P=0.00; (60.20 ±3.52)mm Hg vs.(56.25 ±3.09)mm Hg,t =8.97,P =0.00; (38.93 ±2.96) ％ vs.(40.70 ±3.27)％,t =26.38,P =0.00; (180.55 ±4.78) μg/L vs.(173.05 ± 5.28) μg/L,t =6.66,P =0.00).The frequency of acute exacerbations of COPD and hospital stay days were significantly decreased in the experimental group than in the control group.Conclusion Long-term NIPPV combined with inhaling corticosteroids could significantly improve the quality of life and lower the serum levels of MMP-9 of patients with severe stable COPD complicated with respiratory failure. Key words: Chronic obstructive pulmonary disease; Respiratory failure; Non-invasive positive pressure ventilation; Corticosteroids; Matrix metalloproteinase-9

Effects of non-invasive positive pressure ventilation on oxidative stress and right ventricular overload of COPD patients

Efficacy and Impact on Serum Matrix Metalloproteinase-9 of Long-Term Non-Invasive Positive Pressure Ventilation Combined with Inhaling Corticosteroids in Patients with Stable Severe Chronic Obstructive Pulmonary Disease Complicated with Respiratory Failure

Evaluation of the Effectivenesss of Noninvasive Positive Pressure Ventilation As a Weaning Strategy in Patients with Acute Respiratory Failure

Effect of Noninvasive, Positive Pressure Ventilation on Patients with Severe, Stable Chronic Obstructive Pulmonary Disease: a Meta-Analysis.

Noninvasive positive pressure ventilation (NPPV) therapy for elderly patients with moderate and severe COPD

Study on the therapeutic effects and prognosis evaluation of non-invasive ventilation in patients with chronic obstructive pulmonary disease with lung cancer

Clinical Efficacy Evaluation of Non-Invasive Positive Pressure Ventilation on Acute Coronary Syndrome Accompanied by Acute Left Heart Failure

Relevant Factors Which Influence Effects of Noninvasive Positive Pressure Ventilation on Severe COPD Patients with Respiratory Failure

Clinical Investigation of Non-Invasive Positive Pressure Ventilation in Treatment for Patients with Chronic Obstructive Pulmonary Disease and Severe Respiratory Failure Complicated with Hypercapnia

Efficacy and Safety of Noninvasive Positive Pressure Ventilation in the Patients with Respiratory Failure Due to Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Conscious Disturbances

[Prospective Randomized Controlled Clinical Study of Early Use of Noninvasive Positive Pressure Ventilation in the Treatment for Acute Exacerbation of Chronic Obstructive Pulmonary Disease].

Clinical significance and changes of plasma brain natriuretic peptide level in patients with chronic obstructive pul monary disease under different conditions

The clinic study of Non-invasive positive pressure ventilation (NIPPV) on 63 cases with typeⅠ respiratory failure

Effect of Bi-level Positive Airway Pressure Ventilation Combined with Seretide on Quality of Life of Elder Patients with Moderate and Severe Chronic Obstructive Pulmonary Disease and Type Ⅱ Respiratory Failure

The Clinical Value of Noninvasive Ventilation in Chronic Hypercapnic Respiratory Failure--a 3-Year Retrospective Study

Effect of Bronchial Lavage Combined with Non-Invasive Positive Pressure Ventilation in Rescuing of Respiratory Failure in Chronic Obstructive Pulmonary Disease Patients

[The Efficacy and Safety of Long Term Home Noninvasive Positive Pressure Ventilation in Patients with Stable Severe Chronic Obstructive Pulmonary Disease].

Analysis on the curative effects of different respiratory stimulants combined with non-invasive positive pressure ventilation in the treatment of chronic obstructive pulmonary disease with respiratory failure

Observation on the Effect of Non-Invasive Ventilator Combined with Conventional Therapy in the Treatment of Chronic Obstructive Pulmonary Disease Complicated with Respiratory Failure

Effects of prophylactic use of noninvasive positive pressure ventilation following stanford type A aortic dissection operation

Clinical efficacy of HI-NPPV in the treatment of AECOPD combined with severe type II respiratory failure